4//SEC Filing
Jindal Vineet R. 4
Accession 0001209191-21-053523
CIK 0001637715other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:54 PM ET
Size
5.0 KB
Accession
0001209191-21-053523
Insider Transaction Report
Form 4
Jindal Vineet R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-08-25$7.44/sh+5,000$37,177→ 5,000 total
Footnotes (1)
- [F1]The weighted average purchase price for the transaction was $7.4353. The shares were purchased at a range of prices between $7.39 and $7.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001855115
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:54 PM ET
- Size
- 5.0 KB